G, L. T., N, C., JC, B., V, B., RB, D., J, T., . . . MC, E. (2024). Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis. British journal of cancer, 130(5), 808. https://doi.org/10.1038/s41416-023-02517-2
Chicago Style (17th ed.) CitationG, Le Teuff, et al. "Dihydropyrimidine Dehydrogenase Gene Variants for Predicting Grade 4-5 Fluoropyrimidine-induced Toxicity: FUSAFE Individual Patient Data Meta-analysis." British Journal of Cancer 130, no. 5 (2024): 808. https://doi.org/10.1038/s41416-023-02517-2.
MLA (9th ed.) CitationG, Le Teuff, et al. "Dihydropyrimidine Dehydrogenase Gene Variants for Predicting Grade 4-5 Fluoropyrimidine-induced Toxicity: FUSAFE Individual Patient Data Meta-analysis." British Journal of Cancer, vol. 130, no. 5, 2024, p. 808, https://doi.org/10.1038/s41416-023-02517-2.